Third Rock Ventures III L.P. 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:19 pm Unchanged |
2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Third Rock Ventures III L.P. | 2,343,154 3.800% |
0 (Unchanged) |
Filing |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Third Rock Ventures III L.P. | 2,343,154 4.500% |
-1,703,271 (-42.09%) |
Filing |
| 2022-02-14 5:06 pm Sale |
2021-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Third Rock Ventures III L.P. | 4,046,425 10.000% |
-1,915,777 (-32.13%) |
Filing |